Self-administration of injectable medications carries risks including infection, incorrect dosing, and adverse reactions
We currently do not have a payment methodology specifically for SaaS, and as these technologies have continued to evolve and diversify, some interested parties have stated that the lack of a consistent payment policy for SaaS can be an impediment to patient access when these services are otherwise approved by the FDA
Yes, its a good practice
Rest assured, it's safe for daily use
Section 1833(t)(1)(B) of the Act provides for payment under the OPPS for hospital outpatient services designated by the Secretary (which includes partial hospitalization services furnished by CMHCs), and certain inpatient hospital services that are paid under Medicare Part B
Similarly, if cationic resins are severely contaminated by iron or heavy metals such that their exchange capacity cannot be restored, or if the resin structure has been compromised by strong oxidizers (causing the resin to soften and fracture), regeneration cannot restore performance, and replacement is the only viable option